Molecular Basis for the Selectivity of Antituberculosis Compounds Capreomycin and Viomycin

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2011-07-18

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1128/AAC.00628-11PMID 21768509PMCID PMC3187005
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the in vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosis

  2010cited by this paper
• The structures of the anti-tuberculosis antibiotics viomycin and capreomycin bound to the 70S ribosome

  2010cited by this paper
• Quantitative Drug Susceptibility Testing of Mycobacterium tuberculosis by Use of MGIT 960 and EpiCenter Instrumentation

  2009cited by this paper
• Sequence Analyses of Just Four Genes To Detect Extensively Drug-Resistant Mycobacterium tuberculosis Strains in Multidrug-Resistant Tuberculosis Patients Undergoing Treatment

  2009cited by this paper
• High Level of Cross-Resistance between Kanamycin, Amikacin, and Capreomycin among Mycobacterium tuberculosis Isolates from Georgia and a Close Relation with Mutations in the rrs Gene

  2009cited by this paper
• Mitochondrial deafness alleles confer misreading of the genetic code

  2008cited by this paper
• Tuberculosis: drug resistance, fitness, and strategies for global control

  2008cited by this paper
• Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity

  2008cited by this paper
• Mutations in Conserved Helix 69 of 23S rRNA of Thermus thermophilus That Affect Capreomycin Resistance but Not Posttranscriptional Modifications

  2008cited by this paper
• Conservation of bacterial protein synthesis machinery: initiation and elongation in Mycobacterium smegmatis.

  2008cited by this paper
• Antimicrobial agents targeting the ribosome: the issue of selectivity and toxicity — lessons to be learned

  2007cited by this paper
• The antibiotic viomycin traps the ribosome in an intermediate state of translocation

  2007cited by this paper
• Engineering the rRNA decoding site of eukaryotic cytosolic ribosomes in bacteria

  2007cited by this paper
• Capreomycin binds across the ribosomal subunit interface using tlyA-encoded 2'-O-methylations in 16S and 23S rRNAs.

  2006cited by this paper
• Inhibition of Mammalian Mitochondrial Protein Synthesis by Oxazolidinones

  2006cited by this paper
• Discrimination between defects in elongation fidelity and termination efficiency provides mechanistic insights into translational readthrough.

  2005cited by this paper
• Antimicrobial agents: antibacterials and antifungals.

  2005cited by this paper
• Molecular Analysis of Cross-Resistance to Capreomycin, Kanamycin, Amikacin, and Viomycin in Mycobacterium tuberculosis

  2005cited by this paper
• Mutagenesis of 16S rRNA C1409-G1491 base-pair differentiates between 6'OH and 6'NH3+ aminoglycosides.

  2005cited by this paper
• Mutation of tlyA Confers Capreomycin Resistance in Mycobacterium tuberculosis

  2005cited by this paper
• Conformational changes of the small ribosomal subunit during elongation factor G-dependent tRNA-mRNA translocation.

  2004cited by this paper
• Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family.

  2004cited by this paper
• American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.

  2003cited by this paper
• Worldwide incidence of multidrug-resistant tuberculosis.

  2002cited by this paper
• Fitness Cost of Chromosomal Drug Resistance-Conferring Mutations

  2002cited by this paper
• American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis

  2002cited by this paper
• Structural basis for selectivity and toxicity of ribosomal antibiotics

  2001cited by this paper
• Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics.

  1999cited by this paper
• RecA-Mediated Gene Conversion and Aminoglycoside Resistance in Strains Heterozygous for rRNA

  1999cited by this paper
• Community based approaches to the control of multidrug resistant tuberculosis: introducing “DOTS-plus”

  1998cited by this paper
• Fitness of antibiotic-resistant microorganisms and compensatory mutations

  1998cited by this paper
• Mitochondrial ribosomal RNA mutation associated with both antibiotic–induced and non–syndromic deafness

  1993cited by this paper
• Chloramphenicol toxicity: 25 years of research.

  1989cited by this paper
• Chloramphenicol toxicity: 25 years of research.

  1989cited by this paper
• Induction of translational errors (misreading) by tuberactinomycins and capreomycins.

  1980cited by this paper
• Viomycin resistance: alterations of either ribosomal subunit affect the binding of the antibiotic to the pair subunit and the entire ribosome becomes resistant to the drug.

  1979cited by this paper
• Resistance to viomycin conferred by RNA of either ribosomal subunit

  1978cited by this paper
• The inhibition of ribosomal translocation by viomycin.

  1977cited by this paper
• Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin.

  1977cited by this paper
• Cross-resistance relationships between capreomycin, kanamycin, and viomycin resistances in tubecle bacilli from paients.

  1969cited by this paper
• IN VITRO AND IN VIVO LABORATORY STUDIES ON THE ANTITUBERCULOUS ACTIVITY OF CAPREOMYCIN

  1966cited by this paper
• Misreading of RNA codewords induced by aminoglycoside antibiotics.

  1965cited by this paper

• Key Proteins and Enzymatic Mechanisms Underlying Drug Resistance in Mycobacterium tuberculosis.

  2026cites this paper
• Distant ribose 2′-O-methylation of 23S rRNA helix 69 pre-orders the capreomycin drug binding pocket at the ribosome subunit interface

  2025cites this paper
• Recent efforts in the development of glycoconjugate vaccine and available treatment for tuberculosis.

  2024cites this paper
• In vivo screening for toxicity-modulating drug interactions identifies antagonism that protects against ototoxicity in zebrafish

  2024cites this paper
• DISTANT RIBOSE 2’-O-METHYLATION OF 23S rRNA HELIX 69 PRE-ORDERS THE CAPREOMYCIN DRUG BINDING POCKET AT THE RIBOSOME SUBUNIT INTERFACE

  2024cites this paper
• Environment-Responsive Peptide Dimers Bind and Stabilize Double-Stranded RNA.

  2023cites this paper
• Structural analysis of mitochondrial rRNA gene variants identified in patients with deafness

  2023cites this paper
• How do Mutations of Mycobacterium Genes Cause Drug Resistance in Tuberculosis?

  2023cites this paper
• Mycobacterium tuberculosis cell-wall and antimicrobial peptides: a mission impossible?

  2023cites this paper
• Our current understanding of the toxicity of altered mito-ribosomal fidelity during mitochondrial protein synthesis: What can it tell us about human disease?

  2023cites this paper
• Evaluation of Susceptibility of the Human Pathogen Helicobacter pylori to the Antibiotic Capreomycin

  2022cites this paper
• MDR Tuberculosis Treatment

  2022cites this paper
• Tuberactinomycin antibiotics: Biosynthesis, anti-mycobacterial action, and mechanisms of resistance

  2022cites this paper
• Mutational analysis of TlyA from Brachyspira hampsonii reveals two key residues conserved in pathogenic bacteria responsible for oligomerization and hemolytic activity.

  2021cites this paper
• Ototoxicity of Non-aminoglycoside Antibiotics

  2021influential citation
• The structural basis for inhibition of ribosomal translocation by viomycin

  2020cites this paper
• Assessing capreomycin resistance on tlyA deficient and point mutation (G695A) Mycobacterium tuberculosis strains using multi-omics analysis.

  2019cites this paper
• A review on anti‐tuberculosis peptides: Impact of peptide structure on anti‐tuberculosis activity

  2019cites this paper
• Molecular Basis of Drug Resistance in Mycobacteria

  2019cites this paper
• Binding energies of the drugs capreomycin and streptomycin in complex with tuberculosis bacterial ribosome subunits.

  2019cites this paper
• Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies.

  2018cites this paper
• Peptides having antimicrobial activity and their complexes with transition metal ions.

  2018cites this paper
• A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study

  2018cites this paper
• The Mechanisms of Action of Ribosome-Targeting Peptide Antibiotics

  2018cites this paper
• [Drug resistance in Mycobacterium tuberculosis: contribution of constituent and acquired mechanisms].

  2018cites this paper
• Lekooporność w gruźlicy - aspekty mikrobiologiczne i kliniczne.

  2017cites this paper
• Antimicrobial Drug Resistance

  2017cites this paper
• Antimycobacterial Agents: To Target or Not to Target

  2017cites this paper
• Mechanisms of Action and Resistance of the Antimycobacterial Agents

  2017cites this paper
• Nucleoside analogues and tuberculosis: new weapons against an old enemy

  2017cites this paper
• Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement.

  2016cites this paper
• A tale of two antibiotics : Fusidic acid and Viomycin

  2016cites this paper
• Nonmutational compensation of the fitness cost of antibiotic resistance in mycobacteria by overexpression of tlyA rRNA methylase

  2016cites this paper
• Best practice guidelines to monitor and prevent hearing loss related to drug resistant tuberculosis treatment

  2015cites this paper
• Development of Mycobacterium tuberculosis ribosomal RNA as a drug target

  2015cites this paper
• Nucleoside analogs and tuberculosis: new weapons against an old enemy.

  2015cites this paper
• Evaluation of the AID TB Resistance Line Probe Assay for Rapid Detection of Genetic Alterations Associated with Drug Resistance in Mycobacterium tuberculosis Strains

  2014cites this paper
• tRNAs as Antibiotic Targets

  2014cites this paper
• State Key Laboratory of Bioactive Substances and Function of Natural Medicine

  2014cites this paper
• The Antituberculosis Antibiotic Capreomycin Inhibits Protein Synthesis by Disrupting Interaction between Ribosomal Proteins L12 and L10

  2014cites this paper
• Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand

  2014cites this paper
• Spectinamides: A New Class of Semisynthetic Anti-Tuberculosis Agents that Overcome Native Drug Efflux

  2014cites this paper
• In vitro antimicrobial activity of squalamine derivatives against mycobacteria.

  2013cites this paper
• Ribosome-targeting antibiotics and mechanisms of bacterial resistance

  2013cites this paper
• Homology model of 30S ribosomal subunit from Mycobacteria tuberculosis

  2013cites this paper
• Elements of ribosomal drug resistance and specificity.

  2012cites this paper
• Old and New TB Drugs: Mechanisms of Action and Resistance

  2012cites this paper